Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

108 results about "Cell membrane structures" patented technology

Cell membranes are, at their most basic, composed of a phospholipid bilayer with some surface proteins embedded around the surface. Plasma membranes contain phospholipids, cholesterol, proteins and carbohydrates that are arrayed in regular, repeating rows to form a highly plastic surface for the cell. Cell membranes are not solid structures.

Method for constructing simulated outer cell membrane structure coating on material surface by RAFT (reversible addition fragmentation chain transfer) polymerization technology

The invention discloses a method for constructing a simulated outer cell membrane structure coating on a material surface by an RAFT (reversible addition fragmentation chain transfer) polymerization technology, which comprises the following steps of: immobilizing a chain transfer agent 4-cyanopentanoic acid dithiobenzoate on the material surface via primary amino grafting on substrate surface by acylation; then performing free radical polymerization with polymerizable monomers of methacryloyloxyethyl phosphorylcholine in solution to obtain the coating modified by grafted polymers on the surface. The method provided by the invention obtains PMPC (polymerized methacryloyloxyethyl phosphorylcholine) molecular brushes with controllable molecular weight and narrow molecular weight distribution on the surface by grafting and polymerizing the MPC (methacryloyloxyethyl phosphorylcholine) on the surface through the RAFT polymerization; a good effect of resisting against platelet adhesion is reflected on the modified substrate surface of the prepared simulated outer cell membrane structure; and the prepared coating is useable as the coating on the surface of blood contact materials such as artificial hearts, artificial blood vessels and hemodialyzers.
Owner:NORTHWEST UNIV(CN)

Electroporation disinfecting device, method and application of nanowire modified three-dimensional electrodes

The invention discloses an electroporation disinfecting device, method and application of nanowire modified three-dimensional electrodes, and belongs to the technical field of water treatment and disinfection. The device consists of two nanowire modified three-dimensional electrodes, two insulation slots, two wires, a plastic net and a power supply, wherein the two nanowire modified three-dimensional electrodes are respectively fixed to the two insulation slots, the space between the two nanowire modified three-dimensional electrodes is equal to or larger than 5mm, and the plastic net is placed between the two nanowire modified three-dimensional electrodes; the two nanowire modified three-dimensional electrodes are respectively connected with the positive electrode and the negative electrode of the power supply through the two wires. After the power supply is switched on, water to be treated is disinfected through the nanowire modified three-dimensional electrodes. According to the disinfecting method, low-voltage operation is utilized, the electrolytic reaction of a solution is avoided, chlorine is not generated, and efficient safe disinfection is realized; during the disinfection, the cell membrane structure of microorganisms is destroyed, the revival phenomenon cannot occur, the water safety is further guaranteed, and the disinfecting method can be widely used in the technical field of the water treatment and the disinfection.
Owner:TSINGHUA UNIV

Preparation method for ZCHH tablets and method for reversing drug tolerance of MRSA (Methicillin-Resistant Staphylococcus Aureus) by using ZCHH and antibiotic together

The invention discloses a preparation method for ZCHH tablets and a method for reversing the drug tolerance of MRSA (Methicillin-Resistant Staphylococcus Aureus) by using ZCHH and an antibiotic together. The preparation method comprises the following steps: thoroughly mixing ZCHH with lactose according to the weight ratio of the ZCHH to the lactose of 40 to 9; preparing wet granules with starch slurry of 10%; treating the wet granules with a 16-mesh sieve; drying at 60-70 DEG C; after granule straightening, adding magnesium stearate of which the weight is 1% of that the granules to the granules; compressing to form the ZCHH tablets. The method for reversing the drug-tolerance of the MRSA by using the ZCHH and the antibiotic together comprises the following steps: MRSA strains are isolated clinically; only ZCHH as well as both ZCHH and a beta-lactam antibiotic are applied to in vitro bacteriostasis; only ZCHH as well as both ZCHH and a beta-lactam antibiotic are applied to in vivo bacteriostasis; the structural hierarchies of the cell walls and cell membranes of the MRSA bodies are observed; statistical analysis is performed on the in vivo and in vitro antibiosis effects of the ZCHH and the beta-lactam antibiotics which are used together. According to the invention, the dead zone of action mechanism that the drug tolerance of the MRSA is reversed through drug combination is filled up, and an important theoretical basis is provided for clinical medication.
Owner:曾春晖

Paraboloid condensation and hot steam pulsation combined multistage falling-membrane seawater desalination device

The invention discloses a paraboloid condensation and hot steam pulsation combined multistage falling-membrane seawater desalination device. The paraboloid condensation and hot steam pulsation combined multistage falling-membrane seawater desalination device comprises a compound parabolic concentrator, a convex transparent material, water distributors, a heat receiver and a semipermeable membrane. Light rays are focused on the heat receiver after entering the compound parabolic concentrator and being subjected to reflection of the inner surface and secondary reflection of the vertical wall face, and with temperature rising continuously, the heat receiver heats seawater. A bottom chamber is similar to a cytomembrane structure, the seawater evaporates continuously, and pressure in the chamber increases to enable bottom hot seawater to be pumped from a guide pipe into the top water distributor by means of pulsation and then form falling-membrane flowing on the upper surface of a convex. Steam close to a lower chamber condensates on the lower surface of the convex, and heat is transferred to a falling-membrane water body on the upper surface to enable the steam to evaporate. The seawater flows down stage by stage under the action of gravity, the concentration of the seawater in the bottom chamber increases, and external seawater is supplied due to the fact that pure water decreases in the chamber under the action of the semipermeable membrane on the bottom side of the chamber. Fresh water tanks disposed on reflection surfaces of evaporation chambers in all layers are used for outputting fresh water.
Owner:BEIJING INSTITUTE OF TECHNOLOGYGY

Protective agent for freeze-dried preservation of genetic engineering mushroom strains and preserving method of genetic engineering mushroom strains

The invention discloses a protective agent used in a freeze-dried preservation method of genetic engineering mushroom strains and a preserving method of genetic engineering mushroom strains. An ediblemushroom strain fermenting substance used in the technical scheme of the invention is used as the protective agent for freeze-dried preservation of the strains. Cultivation substances are fermented through edible mushroom strains such as cohabitant fungi, so that lignin and cellulose which are not liable to decompose at the normal state can be decomposed, organic compounds are fermented to decompose, and fermentation products and degradation substances contain various active micromolecules, such as micromolecular peptide, oligosaccharide and other low molecular weight substances of which thespecific chemical composition is still not found, which can maintain the integrity of cell membrane structure and protect the cell protein structure from being destructed. The implementation of the scheme proves that when an experimental group with the protective agent disclosed by the scheme of the invention is compared with a control group to which the protective agent disclosed by the scheme ofthe invention is not added, the technical effects of the experimental group scheme are obviously better, which proves that the strain fermentation substances have the advantages in the respect of maintaining the survival rate and the production properties of the strains.
Owner:GUANGZHOU GENSOURCE BIO TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products